Neola Medical AB (publ), together with its subsidiary, Neola Medical, Inc., develops medical technology devices for non-invasive continuous monitoring of the lungs of preterm born infants in Sweden. It offers NEOLA, a neonatal intensive care medical device that enables continuous lung monitoring and real-time alerts of life-threatening complications using technology that measures lung volume changes and oxygen gas concentration. The company was formerly known as GPX Medical AB and changed its name to Neola Medical AB (publ) in June 2022. Neola Medical AB (publ) was incorporated in 2016 and is headquartered in Lund, Sweden.…
Neola Medical | Investing in Life Science 2026
Neola Medical (STO: NEOLA) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 9 employees.
The shares were at 0.5050 SEK on 20 November 2026, down 63.9% over 52 weeks. Its 52-week range is 0.4440 SEK to 1.850 SEK: the price is 72.7% below the high and 13.7% above the low.
Its market capitalisation is 55.79M SEK.
Neola Medical reports return on equity of -14.5% and an operating margin of -362.5%.
It holds more cash than debt, a net cash position of 27.01M SEK. Its Piotroski F-score is 2 out of 9, a weak reading of its financial health.
No upcoming events tracked.